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ABSTRACT
Objective To determine the long term effects of antibiotic
treatment for acute otitis media in young children.
Design Prospective three year follow-up study within the
framework of a primary care based, double blind,
randomised, placebo controlled trial.
Setting 53 general practices in the Netherlands.
Participants 168 children aged 6 months to 2 years with
acute otitis media.
Interventions Amoxicillin 40 mg/kg/day in three doses
compared with placebo.
Main outcome measures Recurrence of acute otitis
media; referral to secondary care; ear, nose, and throat
surgery.
Results Acute otitis media recurred in 63% (47/75) of
children in the amoxicillin group and in 43% (37/86) of
the placebo group (risk difference 20%, 95% confidence
interval 5% to 35%); 30% (24/78 amoxicillin; 27/89
placebo) of children in both groups were referred to
secondarycare,and21%(16/78)oftheamoxicillingroup
compared with 30% (27/90) of the placebo group had
ear, nose, and throat surgery (risk difference −9%, −23%
to 4%).
Conclusion Recurrent acute otitis media occurred more
often in the children originally treated with amoxicillin.
Thisisanotherargumentforjudicioususeofantibioticsin
children with acute otitis media.
Trial registration Netherlands Trial Register NTR1426.
INTRODUCTION
Acuteotitismedia,oneofthemostcommoninfections
in childhood, remains the leading cause of doctors’
consultations by children and the most common rea-
sonforchildrentotakeantibiotics.
1Currentguidelines
recommendprescriptionofantibioticsinchildrenwith
severe illness and in those younger than 2 years of age
withbilateralacuteotitismediaoracuteotorrhoea.For
most other children with acute otitis media, initial
observation is recommended.
2-4
So far, little is known about the long term effects of
antibiotics in acute otitis media. Initial prescription of
antibiotics may on the one hand shorten the course of
acute otitis media.
56On the other hand, it may encou-
rage doctors’ attendance in future episodes, increase
pressure on doctors to prescribe, increase future use
of antibiotics, and therefore increase antibiotic
resistance.
78 In addition, antibiotic treatment may
cause an unfavourable shift towards colonisation with
resistantpathogens,whichare likelytopromoterecur-
rence of the infection.
9-12 We aimed to study the long
term effects of antibiotics on recurrence of acute otitis
media; referrals to secondary care; and ear, nose, and
throat surgery.
METHODS
We did the study within the framework of a primary
care based, randomised, placebo controlled, double
blind trial on the effects of amoxicillin compared with
placebo in children with acute otitis media aged
between6and24months.
5Thediagnosisofacuteotitis
mediawasbasedonthepresenceofacutesignsofinfec-
tionandotoscopy.Theoriginalstudytookplaceinthe
Netherlands between February 1996 and May 1998
andincluded240children,whowerefollowedactively
forsixmonths.
513Attrialentry,parentswereinformed
that treatment allocation would be revealed only after
the final follow-up, including the post-trial period of
aboutthreeyears.Onlyincaseofseverecomplications
orsideeffectswouldthetreatmentcodebebrokendur-
ing the trial. The results at days four and 11 and at six
months were reported in 2000 and 2006.
513
In 2000—that is, approximately three and half years
after the start of the trial—we sent a questionnaire to
parents of the participating children, asking them
about episodes of recurrent acute otitis media; referral
to secondary care; and ear, nose, and throat surgery.
We defined the primary outcome measure, reported
recurrent acute otitis media, as at least one episode of
acute otitis media that occurred between the last study
appointment at six months and the current survey. In
addition, we compared the proportion of children
referred to secondary care (paediatrician or ear, nose,
andthroatsurgeon)andtherateofear,nose,andthroat
surgery.
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and did not adjust for potential confounders, as we
werereportingonthelongtermeffectsofarandomised
placebo controlled trial. To be sure that confounding
was not a problem in the post-randomisation period,
wealsostudiedthefollowingpotentialconfoundersby
using logistic regression analysis: mean age at inclu-
sion, sex, breast feeding, number of siblings, season
of inclusion, attendance at day care centre, family his-
tory of recurrent upper respiratory tract infections,
(duration of) symptoms at presentation, subsequent
use of antibiotics within six months, and the clinical
outcome at days four and 11 and six months.
Finally, we did a sensitivity analysis on the primary
outcome restricted to the children in each group who
didnotreceiveantibioticswithinthefirstsixmonthsof
thepost-trialfollow-upperiod.Wedidallanalyseswith
SPSS 14.0 on an intention to treat basis.
RESULTS
Of the 240 participants originally randomised, 168
(70%) returned the questionnaire. At this stage, about
95% of these parents were still blinded to the original
treatment. The baseline characteristics of these 168
children were similar to those initially randomised
(table 1).
Three years after randomisation, acute otitis media
hadrecurredin47/75(63%)childrenintheamoxicillin
group compared with 37/86 (43%) children in the pla-
cebogroup(riskdifference20%,95%confidenceinter-
val 5% to 35%) (table 2). Logistic regression analysis
showed that sex, allergy, and history of recurrent
acute otitis media might be relevant confounding fac-
tors. Adjustment for these factors resulted in an
adjusted odds ratio of 2.5 (95% confidence interval
1.2 to 5.0)—that is, children who were assigned to the
amoxicillin group had a 2.5 times higher risk of recur-
rent acute otitis media than children in the placebo
group.
Twenty four out of 78 (31%) children in the amoxi-
cillin group and 27/89 (30%) in the placebo were
referred to secondary care (risk difference 0%, −14%
to 14%) (table 2). Finally, 16/78 (21%) children in the
amoxicillin group compared with 27/90 (30%) chil-
dren in the placebo group had ear, nose, and throat
surgery (risk difference −9%, −23% to 4%).
Sensitivity analysis for the primary outcome mea-
sure, comparing only those children in each group
who did not receive antibiotics in the first six months
of the post-trial follow-up period, showed a risk differ-
enceof32%(13%to51%)andanadjustedoddsratioof
4.4 (1.7 to 11.5).
Table 1 |Baseline characteristics. Values are numbers (percentages) unless stated otherwise
Characteristic
Trial (n=240) Long term survey (n=168)
Amoxicillin (n=117) Placebo (n=123) Amoxicillin (n=78) Placebo (n=90)
Mean age at inclusion (months) 13.3 13.4 13.5 13.1
Male 64 (55) 66 (54) 43 (55) 45 (50)
Breast fed for ≥6 months 21 (18) 22 (18) 17 (22) 17 (19)
>2 children in family 30 (26) 25 (20) 19 (24) 18 (20)
Season of inclusion (Oct-March) 76 (65) 79 (64) 52 (67) 60 (67)
Smoking in household 46 (39) 39 (32) 27 (35) 24 (27)
Attendance at day care centre 28 (24) 19 (15) 19 (24) 16 (18)
Medical history:
Recurrent URTI 37 (32) 33 (27) 24 (31) 19 (21)
Recurrent AOM in family 26 (22) 33 (27) 15 (19) 25 (28)
Allergy 14 (12) 9 (7) 7 (9) 7 (8)
Recurrent AOM 33 (28) 50 (41) 21 (27) 33 (37)
Clinical presentation:
>3 days’ complaints 57 (49) 54 (44) 39 (50) 39 (43)
Earache 82 (70) 82 (67) 57 (73) 58 (64)
Fever 79 (68) 80 (65) 51 (65) 54 (60)
Perforation 18 (15) 21 (17) 13 (17) 19 (21)
Bilateral AOM 75 (64) 76 (62) 51 (65) 55 (61)
Bulging ear drum 26 (22) 29 (24) 21 (27) 18 (20)
Mean follow-up (months) NA NA 46 45
Subsequent antibiotic use within
6 months*
39/105 (37) 44/104 (42) 23/73 (32) 32/81 (40)
AOM=acute otitis media; NA=not applicable; URTI=upper respiratory tract infection.
*At least one antimicrobial treatment within six months of end of treatment.
Table 2 |Clinical outcomes between six months and three years after randomised controlled
trial. Values are numbers (percentages) unless stated otherwise
Outcome
Amoxicillin
(n=78)
Placebo
(n=90)
Risk difference
(95% CI)
Relative risk
(95% CI)
Recurrent acute otitis media 47/75 (63) 37/86 (43) 20% (5% to 35%) 1.5 (1.1 to 2.0)
Referral rate 24 (31) 27/89 (30) 0%(−14%to14%) 1.0 (0.6 to 1.6)
Surgery rate 16 (21) 27 (30) −9%(−23%to4%) 0.7 (0.4 to 1.2)
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Using a questionnaire about recurrent episodes of
acute otitis media, we found a 20% higher recurrence
rate in the amoxicillin group compared with the pla-
cebogroupinthepost-trialperiodbetweensixmonths
and three years after randomisation. The correspond-
ingconfidenceintervals,however,arewide,sothisrate
must be interpreted with some caution.
Toourknowledge,wearethefirstgrouptostudythe
long term effects of antibiotics in children with acute
otitis media. Others have studied the effects up to one
year and found no differences between the groups.
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This seems to be in agreement with our results for the
firstsixmonthsoffollow-up,inwhichwefoundsimilar
recurrence rates in the amoxicillin and placebo group
(51% v 50%; risk difference 1%, 95% confidence inter-
val −12% to 15%).
Our findings might be explained by unfavourable
changes in the colonisation of the nasopharynx as a
result of the use of antibiotics, as reported
previously.
9-12 Alternatively, the use of antibiotics
early in an episode of acute otitis media may impair
the natural immune response and weaken the protec-
tion against further episodes, as has been suggested in
studies of bacterial pharyngitis.
15-17 Importantly, both
possibleexplanationswouldprimarilyhaveresultedin
a difference in recurrence of acute otitis media in the
first six months of follow-up, which was not the case.
Nevertheless,ourfindingsareveryrobust:unadjusted,
adjusted, and sensitivity analyses showed a relevant
clinical difference.
The major strength of our study is the fact that most
parents were still blinded to the original treatment
when they filled in the questionnaire. Furthermore,
byusingaquestionnairewemeasuredtruerecurrences
rather than reattendances.
Some possible limitations deserve further discus-
sion. Firstly, under-reporting or over-reporting of
acuteotitismediacannotfullybeprecluded,astheout-
comeswere basedonparental reports.Therecurrence
rates might therefore be biased,but we would expect a
similareffectinbothgroups,especiallyasmostparents
werestillblindedwhentheyparticipatedinthecurrent
survey. Thus recall bias is unlikely.
Secondly,70%oftheparentswhoparticipatedinthe
randomised controlled trial returned the question-
naire. This might potentially have led to selection of
otitis prone children. The baseline characteristics of
the children whose parents responded were, however,
similar to those of the original trial population.
Thirdly, we did not do a Cox regression analysis, as
we measured only the number of recurrent episodes
after three years. As the mean follow-up times were
similar in both groups, however, we do not expect
that Cox regression would have changed our results.
Fourthly, our results can be generalised only to
otherwise healthy children in well resourced settings.
Acute otitis media can become a serious illness in chil-
dren at risk and in those in less resourced settings, and
this may call for a more active approach to treatment.
Fifthly, owing to the delay in reporting the results of
this survey, changes in practice since then may have
reduced the applicability of our results. As antibiotics
arestillwidelyprescribedinyoungchildrenwithacute
otitis media,
18 however, we believe that the results of
ourstudyarestillapplicabletocurrentdaytodayprac-
tice.
In conclusion, recurrent acute otitis media occurred
more often in the children originally treated with
amoxicillin. This is another argument for judicious
use of antibiotics in children with acute otitis media.
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